4th annual Biosimilars North America Renaissance Woodbridge Hotel, 515 US-1, Iselin, NJ, 08830, USA 15-16 November 2017

Description:
The first biosimilar product launched in the US in 2015. Currently there are only 4 biosimilar products approved but the North Americas market continues to grow and has become highly lucrative. As such, pharmaceutical companies continue to find ways to differentiate their products in such a saturated market. Thus, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development, and ensure optimal market access and commercialization opportunities whilst complying with evolving regulatory requirements.

This year, the conference will also explore significant developmental topics within the sector including the impact of FDA’s newly implemented biosimilar interchangeability guidelines, the US market access landscape, and biosimilars of orphan drugs.

Booking: https://go.evvnt.com/130541-1

Price:
Book by June 30: USD 1599
Book by September 29: USD 1799
Standard: USD 1899
Workshop: USD 499

Time: on Wednesday November 15, 2017 at 8:30 am (ends Thursday November 16, 2017 at 5:30 pm)